cd38 and ceramide enriched membrane platforms in bovine
play

CD38 and Ceramide-Enriched Membrane Platforms in Bovine Coronary - PowerPoint PPT Presentation

CD38 and Ceramide-Enriched Membrane Platforms in Bovine Coronary Myocytes July 31, 2008 Matt Childrey Department of Pharmacology & Toxicology Medical College of Virginia Virginia Commonwealth University Richmond, Virginia Summer Program


  1. CD38 and Ceramide-Enriched Membrane Platforms in Bovine Coronary Myocytes July 31, 2008 Matt Childrey Department of Pharmacology & Toxicology Medical College of Virginia Virginia Commonwealth University Richmond, Virginia Summer Program for Undergraduate Research 2008

  2. Background • Ceramide-enriched lipid rafts microdomains ceramide sphingomyelin ASM de novo • Oxotremorine CD38 • • 45 kDa

  3. Hypothesis • Lipid raft membrane microdomains are involved in oxotremorine-induced CD38 activation in bovine coronary myocytes. cADPR hydrolysis Calcium CD38 oxotremorine release Lipid raft platform vasoconstriction

  4. Methods •DMT Myograph: tension recording studies of fresh bovine myocardial vasculature •Vasoconstrictor: Oxotremorine (20 uM, 40 uM, 60 uM, 80 uM) •Drugs: Methyl-ß-cyclodextrin (1mM), desipramine (0.1 mM), filipin (1µg/mL), nicotinamide ( 6mM), treated for 15 minutes

  5. Results Oxotremorine-induced Contraction 1000 800 % relative contraction 600 400 200 0 -200 0 uM 20 uM 40 uM 60 uM 80 uM oxotremorine control (n=29) mcd (n=29) desipramine (n=13) filipin (n=16) nicotinamide (n=22) Fig. 1. Effect of LR inhibitors on oxotremorine-induced constriction

  6. Results Methyl-ß-cyclodextrin vs. Control Oxotremorine-induced Contraction (n=29) 700 600 500 % relative contraction 400 300 200 100 0 0 uM 20 uM 40 uM 60 uM 80 uM oxotremorine control mcd

  7. Results Desipramine vs. Control Oxotremorine-induced Contraction 500 400 % relative contraction 300 200 100 0 -100 0 uM 20 uM 40 uM 60 uM 80 uM oxotremorine control (n=29) desipramine (n=13)

  8. Results Filipin vs. Control Oxotremorine-induced Contraction 500 400 % relative contraction 300 200 100 0 0 uM 20 uM 40 uM 60 uM 80 uM oxotremorine control (n=29) filipin (n=16)

  9. Results Nicotinamide vs. Control Oxotremorine-induced Contraction 1000 800 % relative contraction 600 400 200 0 0 uM 20 uM 40 uM 60 uM 80 uM oxotremorine control (n=29) nicotinamide (n=22)

  10. Results

  11. Discussion • CD38 as receptor and enzyme • ASM inhibition • Role of ceramide in CD38 activation? • Raft aggregation and oxotremorine stimulation

  12. Questions and Future Directions • Inhibitor concentrations • Oxotremorine dosage levels • Myograph-specific conditions?

  13. Acknowledgements • Dr.Li and Dr.Zou - special thanks for making this summer possible • VCU Pharmacology & Toxicology

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend